Quick Take #4: September Updates! Part Dexu: New Study on the Benefits of Drug Treatment of ADHD, Case of ChatGPT-induced Bromide Poisoning Psychosis, Another Study of the Ineffectiveness of Gabapentinoids, New GLP-1 Study Results, Wearable Lithium Sensor, New Formulation of Lacanemab, and MORE!!!

Welcome back to part two of my September edition of my psychiatry quick takes episode series. It's been a busy couple months in the news, so I have several more tidbits for September. Today I'm going to talk about a new study on long-term medication treatment of ADHD, psychosis caused by bromide poisoning after consulting ChatGPT, more information about kanna, another study showing that gabapentin just doesn't work that well, a new formulation of lecanemab for Alzheimer's which is easier to take, the latest trial results on the next likely GLP-1, oral orforglipron for weight loss, a fascinating case of a woman who had a fecal microbiota transplant and ceased to have symptoms of bipolar disorder, a new wearable lithium sensor to be hitting the market, and a new synthetic opioid thats 50 times stronger than kratom to be on the look out for. Please have a listen!